BioAge Labs, End Period Cash Flow Over Time
| BIOA Stock | 18.80 0.49 2.54% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out BioAge Labs, Performance and BioAge Labs, Correlation. BioAge |
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioAge Labs,. If investors know BioAge will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioAge Labs, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.40) |
The market value of BioAge Labs, is measured differently than its book value, which is the value of BioAge that is recorded on the company's balance sheet. Investors also form their own opinion of BioAge Labs,'s value that differs from its market value or its book value, called intrinsic value, which is BioAge Labs,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioAge Labs,'s market value can be influenced by many factors that don't directly affect BioAge Labs,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioAge Labs,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if BioAge Labs, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioAge Labs,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities End Period Cash Flow Analysis
Compare BioAge Labs, and related stocks such as Stepstone Group, Kinsale Capital Group, and NI Holdings End Period Cash Flow Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STEP | 20.4 M | 20.4 M | 20.4 M | 20.4 M | 20.4 M | 20.4 M | 20.4 M | 106.3 M | 40.6 M | 89.9 M | 183.9 M | 117.4 M | 129.5 M | 182.3 M | 119.7 M |
| KNSL | 16.2 M | 16.2 M | 16.2 M | 16.2 M | 24 M | 24.5 M | 50.8 M | 81.7 M | 75.1 M | 100.4 M | 77.1 M | 121 M | 156.3 M | 126.7 M | 85.4 M |
| NODK | 21.7 M | 21.7 M | 21.7 M | 21.7 M | 21.7 M | 14.5 M | 18.3 M | 27.6 M | 69 M | 62.1 M | 101.1 M | 70.6 M | 47 M | 56.7 M | 53.8 M |
| UFCS | (2 M) | 144.5 M | 107.5 M | 92.2 M | 90.6 M | 106.4 M | 110.9 M | 95.6 M | 64.5 M | 120.7 M | 87.9 M | 132.1 M | 96.7 M | 102 M | 110.4 M |
| MHLA | 131.9 M | (25.1 B) | 81.5 M | 139.8 M | 108.1 M | 332.5 M | 149.5 M | 149.4 M | 331 M | 107.3 M | 135.8 M | 66.1 M | 46.6 M | 42.7 M | 40.5 M |
| AEG | 378.9 M | 7.8 B | 9.6 B | 5.7 B | 10.6 B | 9.6 B | 11.3 B | 11 B | 8.7 B | 12.3 B | 8.4 B | 6.9 B | 8.5 B | 4.1 B | 5.8 B |
| FDUS | 2.7 M | 39.1 M | 52 M | 53.4 M | 29.3 M | 31.7 M | 57.1 M | 41.6 M | 42 M | 15 M | 124.3 M | 169.4 M | 62.4 M | 119.1 M | 61.7 M |
BioAge Labs, and related stocks such as Stepstone Group, Kinsale Capital Group, and NI Holdings End Period Cash Flow description
My Equities
My Current Equities and Potential Positions
| BioAge Labs, | BIOA |
Specialization | Healthcare, Drug Manufacturers - Specialty & Generic |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
null 18.8
Check out BioAge Labs, Performance and BioAge Labs, Correlation. For information on how to trade BioAge Stock refer to our How to Trade BioAge Stock guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
BioAge Labs, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.